Staff News
By annette
The Swedish Institute for Health Economics welcomes David Gabrielsson who joined our team this week. David works as an Analyst at our Stockholm office.
By annette
The Swedish Institute for Health Economics welcomes David Gabrielsson who joined our team this week. David works as an Analyst at our Stockholm office.
By annette
This retrospective population-based study used Swedish registers with health-data on patients with BC/RCC and matched controls with diabetes but no cancer. The high prevalence of diabetes and increased use of systemic corticosteroid treatment observed in this large national study highlights the need for specific clinical management, risk-assessment, and monitoring of individuals with BC/RCC and diabetes. …
By annette
Following the Covid-19 pandemic in 2020 — 2022, decision makers in Europe imposed nonpharmaceutical interventions (NPIs) to reduce the physical interaction of individuals across the continent. The aim was to reduce the spread of disease; however, the interventions and the behavioral changes also came at a cost, both in terms of quality of life and …
By annette
National Cancer Control Programs (NCCPs) are recognized by the WHO as the gold standard for reducing cancer incidence and mortality in a strategic way. Saudi Arabia is a country working to update its NCCP in 2025. At a workshop with local experts and international speakers from IARC and UICC in Riyadh, IHE’s Thomas Hofmarcher shared …
By annette
What are challenges women with endometrial cancer face in Canada? Our first country-specific case study provides a comprehensive overview of the disease and economic burden and the care pathway. It also provides recommendations for improvement. Read more and download
By annette
The report puts a spotlight on the disease burden, cancer prevention, early detection, and the sustainability of cancer care systems. Läs mer
By annette
How good is cancer care in Lithuania compared to other EU countries and what can be improved? This dashboard-style report provides a visual and quantitative description of selected performance indicators in all areas of cancer care. It focuses specifically on women’s cancers (breast cancer and gynecological cancers). The purpose of the dashboard is to encourage …
By annette
In our latest Insight, Managing Director Peter Lindgren reflects on AI and health economics. There was no doubt about what was one of the big themes of the year at this year’s ISPOR meeting in Barcelona: AI. Although none of the plenary sessions were about exactly this, there were more than ten sessions on AI …
By annette
How good is access to cancer medicines in Italy, and what can other European countries learn from it? A new dashboard-style report provides an in-depth analysis of Italy’s access to innovative cancer medicines, focusing on the Fund for Innovative Drugs (Fondo per i Farmaci Innovativi). The report reveals that Italy performs well in a European …
By annette
Demographic development and advances in medical technology leading to increased treatment opportunities are challenges faced by our health care system. In times with a strained economic situation, the availability of accurate data to make well-founded decisions for health and welfare is more relevant than ever. The newly proposed regulatory framework for health data registers is …